Indications for use drugs: menstrual irregularities associated with the lack of yellow body; mastodynia associated with pain (mastalgia), premenstrual s-m. Pharmacotherapeutic group: G03XB01 - features that affect the sexual sphere. Method of production of drugs: Table., Film-coated, by 3.2-4.8 mg oral drops 50 ml, 100 ml vial. 100 mg, 200 mg. Contraindications to the Infiltrating Ductal Carcinoma of drugs: hypersensitivity to mifepriston, nadnyrkovozalozna failure and prolonged GCS therapy, or G hr. The main pharmaco-therapeutic effects: antiandrogenic, prohestohenna, antyprohestohenna, estrogen and anti-estrogenic effect. 1 p / day in the morning; treatment - 3 months, without interruption during menstruation after discontinuation of the drug overstate the complaints are updated, then in consultation with your doctor treatment should continue. Dosing and Administration of drugs: taken internally; begin treatment during menstruation for the entire course of treatment to apply effective nonhormonal method of contraception, and always necessary to use the minimum effective dose; endometriosis - the recommended dose is 200 - 800 mg here day, overstate usually continues 3 to 6 months; benign fibrocystic mastopathy (including cyclic mastalgia) Emotional Intelligence 100 mg - 400 mg / day treatment course is prolonged from 3 to 6 month hereditary angioedema - 200 mg 2 or 3 g / day, with favorable reaction should find the minimum effective dose for supporting continuous application of preventive medicine. The main pharmaco-therapeutic action: the effects of dopaminergic drugs cause decrease of production of prolactin, ie, eliminate hyperprolactinemia, increased overstate of prolactin secretion violates gonadotropins, resulting in the violation may occur during ripening follicles, ovulation and under a here body, which further leads to the imbalance between estradiol and progesterone, this imbalance between sex hormones cause menstrual irregularities and mastodynia, unlike estrogen and other hormones, prolactin also makes a direct stimulating effect on proliferative processes in the mammary gland, reinforcing connective tissue formation causing enlargement and milk ducts, reducing the prolactin level leads to the inverse of pathological processes in the mammary glands and pain kupiruye c-m rhythmic development and normalization of the ratio of gonadotropic hormones contribute to the normalization of the second phase of the menstrual cycle. Dosing and Administration of drugs: take 1 table. Contraindications to the use of drugs: pregnancy and lactation, elderly and children's age, expressed by human liver, kidney or heart, porphyria, androgen-dependent tumors, undiagnosed abnormal genital bleeding, thrombosis and thromboembolism hour and a history of these diseases. The main pharmaco-therapeutic effects: antyhestahenna, antyprohesteronna action; synthetic steroid tool that blocks the action of progesterone at the receptor, antagonism of glucocorticosteroids by competition at Rheumatoid Factor level of binding to receptors, enhances the contractile ability of myometrium by stimulating the release of interleukin-8 horiodetsydualnyh cells, increasing overstate sensitivity to prostaglandins (to enhance the effect used in combination with overstate prostaglandin analogue) as a result of the drug is peeling detsydualnoyi shell eggs and productive output. Indications for use drugs: Endometriosis - treatment of symptoms associated with endometriosis and / overstate suspension or reduction of the spread endometriotychnyh homes, can be used during surgical procedures or as hormononalnoyi monotherapy in patients who do not respond to other treatment, benign fibrocystic mastopathy - symptomatic pain relief and sensitivity, should be administered only to patients who do not respond to other therapeutic measures or for whom such measures are not Left Lower Quadrant hereditary angioedema. kidney and / or liver failure, porfiriya, uterine cervix, the presence of scar on Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae uterus, anemia, breach of hemostasis (including previous anticoagulant treatment), inflammatory disease of female genital organs, the presence of severe extragenital pathology in women over 35 who smoke ( without consulting physician) for medical termination of pregnancy - suspected ectopic pregnancy, pregnancy is not confirmed by clinical studies for longer than 42 days after cessation of menstruation, which occurred in the application of an intrauterine contraceptive or after withdrawal of hormonal contraception, for induction of labor - hard gestosis, preeclampsia, eclampsia, preterm Pyrexia of Unknown Origin Prolonged pregnancy; hr overstate . Pharmacotherapeutic group: G03XA10 ** - means that affect the sexual sphere.
No comments:
Post a Comment